Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
Severance Hospital, Seoul, Korea, Republic of
The Christ Hospital, Cincinnati, Ohio, United States
Maternité Régionale Universitaire (MRU), Nancy, Lorraine, France
KK Women's and Children's Hospital, Singapore, Singapore
Good Samaritan Hospital, Cincinnati, Ohio, United States
Dept. of Gynecological Surgery and Anesthesia and Intensive Care, Sahlgrenska University Hospital, Goteborg, Sweden
Bispebjerg Hospital, Copenhagen, Denmark
Women's College Hospital, Toronto, Ontario, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.